BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18201118)

  • 21. [Childhood medulloblastoma].
    Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
    Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classic and desmoplastic medulloblastoma: complete case reports and characterizations of two new cell lines.
    Holthouse DJ; Dallas PB; Ford J; Fabian V; Murch AR; Watson M; Wong G; Bertram C; Egli S; Baker DL; Kees UR
    Neuropathology; 2009 Aug; 29(4):398-409. PubMed ID: 19077040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
    Polkinghorn WR; Tarbell NJ
    Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medulloblastoma].
    Bouffet E; Frappaz D; Carrie C; Freycon F; Brunat-Mentigny M
    Pediatrie; 1991; 46(1):71-8. PubMed ID: 1851287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytology of desmoplastic medulloblastoma in imprint smears: a report of 2 cases.
    Riazmontazer N; Daneshbod Y
    Acta Cytol; 2006; 50(1):97-100. PubMed ID: 16514849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
    DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
    Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Histological diagnosis of brain tumors: (19). Medulloblastoma].
    Nagashima K
    No Shinkei Geka; 1992 Jan; 20(1):9-13. PubMed ID: 1738431
    [No Abstract]   [Full Text] [Related]  

  • 28. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
    Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
    J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medulloblastoma. Pathology].
    Siegfried A; Delisle MB
    Neurochirurgie; 2021 Feb; 67(1):28-38. PubMed ID: 29703584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.
    Ellison DW
    Acta Neuropathol; 2010 Sep; 120(3):305-16. PubMed ID: 20652577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.
    Lamont JM; McManamy CS; Pearson AD; Clifford SC; Ellison DW
    Clin Cancer Res; 2004 Aug; 10(16):5482-93. PubMed ID: 15328187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medulloblastoma in two brothers.
    Yamashita Y; Handa H; Toyama M
    Surg Neurol; 1975 Aug; 4(2):225-7. PubMed ID: 1162594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent anaplastic medulloblastoma in cerebrospinal fluid after autologous hematopoietic stem cell transplant.
    Nelson AC; Singh C; Brent Clark H; Pambuccian SE
    Diagn Cytopathol; 2013 Nov; 41(11):980-5. PubMed ID: 22550044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medulloblastomas with favorable versus unfavorable histology: how many small blue cell tumor types are there in the brain?
    Perry A
    Adv Anat Pathol; 2002 Nov; 9(6):345-50. PubMed ID: 12409643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-myc overexpression causes anaplasia in medulloblastoma.
    Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
    Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the prognostic factors in medulloblastoma of children and adults.
    Brandes AA; Paris MK
    Crit Rev Oncol Hematol; 2004 May; 50(2):121-8. PubMed ID: 15157661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.
    Pizer BL; Clifford SC
    Br J Neurosurg; 2009 Aug; 23(4):364-75. PubMed ID: 19637007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medulloblastoma in the nevoid basal-cell carcinoma syndrome: case reports and review of the literature.
    Lacombe D; Chateil JF; Fontan D; Battin J
    Genet Couns; 1990; 1(3-4):273-7. PubMed ID: 2098052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Brain tumors in infants and children--factors affecting prognosis, (Part-3). Mode of metastasis and prognosis in medulloblastoma].
    Oi S; Matsumoto S; Raimondi AJ
    No Shinkei Geka; 1985 Dec; 13(12):1273-80. PubMed ID: 4088449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical management of medulloblastoma in adults.
    Eisenstat DD
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):795-802. PubMed ID: 15485314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.